Phio Pharmaceuticals (PHIO) Current Leases (2011 - 2023)
Phio Pharmaceuticals' (PHIO) quarterly Current Leases came in at $35000.0 in Q4 2023, down 74.07% YoY from $135000.0 in Q4 2022, and down 50.0% on a QoQ basis from $70000.0 in Q3 2023.
Phio Pharmaceuticals (PHIO) Current Leases (2011 - 2023) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 8 years of Current Leases data on file, last reported at $35000.0 in Q4 2023.
- Quarterly Current Leases fell 74.07% year-over-year to $35000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $35000.0 (down 74.07% YoY) and the FY2023 annual result came in at $35000.0, down 74.07% from the prior year.
- Current Leases fell to $35000.0 in Q4 2023, from $70000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $138000.0 in Q1 2023 to a low of $35000.0 in Q4 2023.
- A 5-year average of $110000.0 and a median of $112500.0 in 2020 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases rose 18.48% — and 2023, when it slumped 74.07%.
- Tracing PHIO's Current Leases over 5 years: stood at $107000.0 in 2019, then increased by 8.41% to $116000.0 in 2020, then climbed by 7.76% to $125000.0 in 2021, then advanced by 8.0% to $135000.0 in 2022, then tumbled by 74.07% to $35000.0 in 2023.
- The last three Current Leases figures came in at $35000.0 (Q4 2023), $70000.0 (Q3 2023), and $104000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 138,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 132,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 112,000.00 |
| Jun 30, 2021 | 120,000.00 |
| Mar 31, 2021 | 118,000.00 |
| Dec 31, 2020 | 116,000.00 |
| Sep 30, 2020 | 113,000.00 |
| Jun 30, 2020 | 111,000.00 |
| Mar 31, 2020 | 109,000.00 |
| Dec 31, 2019 | 107,000.00 |
| Sep 30, 2019 | 104,000.00 |
| Jun 30, 2019 | 102,000.00 |
| Mar 31, 2019 | 92,000.00 |